Freshfields Bruckhaus Deringer has advised Shanghai Pharmaceuticals Holding Co. Ltd. (‘Shanghai Pharma’) on its placement of approximately 153m new H-shares on the Hong Kong Stock Exchange….
This content is for Standard 1 Year members only. LoginJoin Now
Author: Michael Patrini
…
This content is for Standard 1 Year members only. LoginJoin Now